| Product Code: ETC7506218 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hungary Oncology NGS Market Overview |
3.1 Hungary Country Macro Economic Indicators |
3.2 Hungary Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Hungary Oncology NGS Market - Industry Life Cycle |
3.4 Hungary Oncology NGS Market - Porter's Five Forces |
3.5 Hungary Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Hungary Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Hungary Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Hungary Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Hungary Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Hungary Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Hungary |
4.2.2 Technological advancements in next-generation sequencing (NGS) for oncology applications |
4.2.3 Growing demand for personalized medicine in oncology |
4.3 Market Restraints |
4.3.1 High costs associated with NGS technology and testing |
4.3.2 Limited reimbursement policies for NGS-based oncology testing in Hungary |
5 Hungary Oncology NGS Market Trends |
6 Hungary Oncology NGS Market, By Types |
6.1 Hungary Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Hungary Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Hungary Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Hungary Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Hungary Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Hungary Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Hungary Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Hungary Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Hungary Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Hungary Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Hungary Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Hungary Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Hungary Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Hungary Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Hungary Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Hungary Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Hungary Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Hungary Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Hungary Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Hungary Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Hungary Oncology NGS Market Import-Export Trade Statistics |
7.1 Hungary Oncology NGS Market Export to Major Countries |
7.2 Hungary Oncology NGS Market Imports from Major Countries |
8 Hungary Oncology NGS Market Key Performance Indicators |
8.1 Adoption rate of NGS technology in oncology diagnostics |
8.2 Number of clinical trials utilizing NGS in oncology research in Hungary |
8.3 Rate of incorporation of NGS results into treatment decisions in oncology practice |
9 Hungary Oncology NGS Market - Opportunity Assessment |
9.1 Hungary Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Hungary Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Hungary Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Hungary Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Hungary Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Hungary Oncology NGS Market - Competitive Landscape |
10.1 Hungary Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Hungary Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here